Why Is Tharimmune (THAR) Stock Moving Today?

Group 1 - Tharimmune is implementing a one-for-15 reverse stock split to consolidate its shares and boost the share price to meet the $1 minimum bid requirement for The Nasdaq Capital Market [1][3] - After the reverse split, Tharimmune will have 785,978 shares of THAR stock remaining [2] - The stock was trading at 33 cents per share prior to the split and has seen a year-to-date decline of 34.5% [3][4] Group 2 - The company aims to remain publicly listed as it is still in the clinical stage of biotechnology, without a product available for sale [4] - As of Friday morning, THAR stock was up 3.7% ahead of the reverse split [4]